No black box warning on record for Biktarvy
As of the latest FDA labeling reviewed, Biktarvy (bictegravir/tenofovir alafenamide/emtricitabine) does not carry a black box warning. Standard warnings and precautions still apply — see the full Biktarvy medicine page for the complete safety profile.